Hims & Hers Health, Inc.
HIMS
$44.72
$0.7051.60%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 88.69% | 85.99% | 69.33% | 56.70% | 50.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 88.69% | 85.99% | 69.33% | 56.70% | 50.15% |
| Cost of Revenue | 152.14% | 142.69% | 93.17% | 56.90% | 35.42% |
| Gross Profit | 74.94% | 73.88% | 64.09% | 56.66% | 53.77% |
| SG&A Expenses | 60.85% | 56.92% | 48.46% | 39.76% | 38.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 78.95% | 73.03% | 57.07% | 43.81% | 38.41% |
| Operating Income | 766.83% | 2,319.30% | 353.75% | 217.93% | 130.62% |
| Income Before Tax | 559.65% | 23,253.41% | 432.44% | 248.34% | 145.16% |
| Income Tax Expenses | -1,909.95% | -1,656.98% | -2,850.73% | -5,597.45% | 1,172.88% |
| Earnings from Continuing Operations | 969.45% | 7,092.56% | 635.28% | 383.65% | 138.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 969.45% | 7,092.56% | 635.28% | 383.65% | 138.54% |
| EBIT | 766.83% | 2,319.30% | 353.75% | 217.93% | 130.62% |
| EBITDA | 498.17% | 2,546.13% | 603.75% | 297.95% | 165.41% |
| EPS Basic | 947.62% | 6,218.70% | 614.87% | 372.93% | 136.91% |
| Normalized Basic EPS | 480.00% | 3,538.78% | 500.73% | 259.52% | 152.93% |
| EPS Diluted | 969.75% | 4,340.74% | 572.02% | 351.63% | 132.82% |
| Normalized Diluted EPS | 475.59% | 4,803.03% | 462.93% | 247.49% | 147.97% |
| Average Basic Shares Outstanding | 3.79% | 3.40% | 3.16% | 2.94% | 2.76% |
| Average Diluted Shares Outstanding | 9.27% | 10.05% | 10.90% | 10.73% | 8.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |